Presenter: James McCormack BSc (Pharm) Pharm D Mike Allan MD
0:00
In episode 452, James and Mike go over 2 recent publications which encapsulate all the important evidence around type 2 diabetes. We talk about the misdirection that occurs with T2DM evidence versus what we do in practice. We now have all the evidence and we know what these medications do or don’t do to important…
Latest Podcasts
BS Medicine Episode #586: It’s time to challenge penicillin allergy labels
In episode 586, Mike and James invite Émélie Braschi back to the podcast to talk about the tricky issue of how to deal with a potential penicillin allergy. Believe it…
BS Medicine Episode #585: PREMIUM – Beta-blockers after an MI and respiratory specialists for COPD
In episode 585, Mike and James finally get back to being PREMIUM. We review the REDUCE-AMI trial which tried to answer the question – do you need to use a…
BS Medicine Episode #584: Remind me, do medications that target brain amyloid improve my dementia?
In episode 584, Mike and James invite Tina Korownyk back to the podcast to talk about the evidence for amyloid-targeting monoclonal antibodies in mild cognitive impairment or Alzheimer’s dementia. Unfortunately,…
May 26, 2021
Presenter(s):
James McCormack BSc (Pharm) Pharm D Mike Allan MD
Please provide any additional comments (optional).